Consistently featured in lists of best biotechs under $10 and is noted for its Cancer BioShield platform targeting lymphopenia.
: Noted for its inhaled therapy for pulmonary arterial hypertension and its recent pursuit of FDA pediatric approval. best biotech stocks to buy under $10
Recent Phase 1b study results for its Crohn's disease treatment showed a favorable safety profile with no serious adverse events. : Consistently featured in lists of best biotechs under